Soininen, Hilkka

Grant Detail

The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.

APP INTERNALIZATION--PREREQUISITE FOR ABETA FORMATION?

Koo, Edward H

1 May 1996 - 30 April 2001
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 330,509

Alzheimer's disease is characterized by the presence of both amyloid plaques and neurofibrillary tangles in cortex. Increasing evidence favors the deposition of amyloid Beta-protein (Abeta) in plaques as an early and possibly primary event in the pathogenesis of Alzheimer's disease, a process that may be related to altered expression or processing of the amyloid precursor protein (APP). To date, the mechanisms that underlie the formation and subsequent deposition of amyloid Beta-protein in brain are unknown. The recent discovery of a constitutive pathway that releases ABeta into media of cultured cells has provided a unique opportunity to understand the mechanism of ABeta production. APP is secreted from cells via a pathway that precludes ABeta formation because of a cleavage within the ABeta domain. Alternatively, APP may be internalized from the cell surface without secretion and directed into the endocytic pathway and ultimately to lysosomes. Results from our preliminary studies suggest that ABeta is generated from endocytosed cell surface APP molecules. These observations lead to the first hypothesis in this proposal: APP that is appropriately targeted to the cell surface and then internalized is the precursor of ABeta released into media. This hypothesis will be examined by two Specific Aims: 1) localization of the proteolytic steps which generate ABeta and secreted APP in transfected mammalian cells, and 2) characterization of the internalization pathway of APP by morphological and biochemical approaches using normal and mutant APP molecules. Although mutations in the APP gene identified in a few cases of familial Alzheimer's disease have provided the strongest link between APP, amyloidogenesis, and the pathogenesis of Alzheimer's disease, how these mutations result in disease or altered cellular metabolism is unknown. Building on the first hypothesis, we suggest in the second hypothesis that APP codon 717 mutations, which lie within the transmembrane domain and beyond ABeta, increase ABeta release by altering APP internalization. This hypothesis will be specifically tested in the final Specific Aim. This investigation represents a detailed study of the APP internalization pathway, which we believe is highly relevant to ABeta production. Results from these studies should provide significant insights into the relationship between APP internalization, APP proteolysis, ABeta release, and familial Alzheimer's disease mutations.

9 Resulting Publications

• 1.

  2001

  S Soriano; D E Kang; M Fu; R Pestell; N Chevallier; H Zheng; E H Koo

  Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing.

  The Journal of cell biology 2001;152(4):785-94.

• 2.

  2000

  D E Kang; C U Pietrzik; L Baum; N Chevallier; D E Merriam; M Z Kounnas; S L Wagner; J C Troncoso; C H Kawas; R Katzman; et al.

  Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

  The Journal of clinical investigation 2000;106(9):1159-66.

• 3.

  1999

  S Soriano; A S Chyung; X Chen; G B Stokin; V M Lee; E H Koo

  Expression of beta-amyloid precursor protein-CD3gamma chimeras to demonstrate the selective generation of amyloid beta(1-40) and amyloid beta(1-42) peptides within secretory and endocytic compartments.

  The Journal of biological chemistry 1999;274(45):32295-300.

• 4.

  1999

  R G Perez; S Soriano; J D Hayes; B Ostaszewski; W Xia; D J Selkoe; X Chen; G B Stokin; E H Koo

  Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42.

  The Journal of biological chemistry 1999;274(27):18851-6.

• 5.

  1999

  H Yuan; P Zhai; L M Anderson; J Pan; B Thimmapaya; E H Koo; N R Marquez-Sterling

  Recombinant adenovirus is an appropriate vector for endocytotic protein trafficking studies in cultured neurons.

  Journal of neuroscience methods 1999;88(1):45-54.

• 6.

  1999

  C S Hong; L Caromile; Y Nomata; H Mori; D E Bredesen; E H Koo

  Contrasting role of presenilin-1 and presenilin-2 in neuronal differentiation in vitro.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(2):637-43.

• 7.

  1998

  J Zhang; D E Kang; W Xia; M Okochi; H Mori; D J Selkoe; E H Koo

  Subcellular distribution and turnover of presenilins in transfected cells.

  The Journal of biological chemistry 1998;273(20):12436-42.

• 8.

  1997

  E H Koo

  Phorbol esters affect multiple steps in beta-amyloid precursor protein trafficking and amyloid beta-protein production.

  Molecular medicine (Cambridge, Mass.) 1997;3(3):204-11.

• 9.

  1997

  C S Hong; E H Koo

  Isolation and characterization of Drosophila presenilin homolog.

  Neuroreport 1997;8(3):665-8.

Scientific Context

This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.